Phase 0 clinical trials: recommendations from the Task Force on Methodology for the Development of Innovative Cancer Therapies

Phase 0 clinical trials: recommendations from the Task Force on Methodology for the Development of Innovative Cancer Therapies

Item
http://www.wikidata.org/entity/Q33985780
The Dark Side of the Moon - the Side Effects of Therapy in a Dynamic Era of Breast Cancer Management.Disease detection by ultrasensitive quantification of microdosed synthetic urinary biomarkers.Phase 0 clinical trials in oncology new drug development.Mathematical framework for activity-based cancer biomarkers.Survivin inhibitor YM-155 sensitizes tumor necrosis factor- related apoptosis-inducing ligand-resistant glioma cells to apoptosis through Mcl-1 downregulation and by engaging the mitochondrial death pathwayMolecularly targeted agents as radiosensitizers in cancer therapy--focus on prostate cancer.Guiding the optimal translation of new cancer treatments from canine to human cancer patients.Radiosensitizers in pancreatic cancer--preclinical and clinical exploits with molecularly targeted agents.Phase zero trials: a novel approach in drug development process.Brain Tumor Clinical Trials: Perspective 2014.Targeting angiogenesis in melanoma
P2860

Phase 0 clinical trials: recommendations from the Task Force on Methodology for the Development of Innovative Cancer Therapies

Item
http://www.wikidata.org/entity/Q33985780
description
2008 nî lūn-bûn
@nan
2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Phase 0 clinical trials: recom ...... of Innovative Cancer Therapies
@ast
Phase 0 clinical trials: recom ...... of Innovative Cancer Therapies
@en
type
label
Phase 0 clinical trials: recom ...... of Innovative Cancer Therapies
@ast
Phase 0 clinical trials: recom ...... of Innovative Cancer Therapies
@en
prefLabel
Phase 0 clinical trials: recom ...... of Innovative Cancer Therapies
@ast
Phase 0 clinical trials: recom ...... of Innovative Cancer Therapies
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
Phase 0 clinical trials: recom ...... of Innovative Cancer Therapies
@en
P2093
Task Force on Methodology for the Development of Innovative Cancer Therapies (MDICT)
P2860
P304
P31
P356
10.1016/J.EJCA.2008.10.024
P433
P478
P577
P5875
P698
P932